Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

This study has been completed.
Information provided by (Responsible Party):
Akros Pharma Inc. Identifier:
First received: October 2, 2012
Last updated: July 25, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2013
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 25, 2013